Display options
Share it on

Mediterr J Hematol Infect Dis. 2013 Sep 02;5(1):e2013053. doi: 10.4084/MJHID.2013.053. eCollection 2013.

Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa.

Mediterranean journal of hematology and infectious diseases

Issoufou Tao, Cyrille Bisseye, Bolni Marius Nagalo, Mahamoudou Sanou, Alice Kiba, Guzin Surat, Tegwindé Rebeca Compaoré, Lassina Traoré, Jean Baptiste Nikiema, Virginio Pietra, Jean-Didier Zongo, Jacques Simpore

Affiliations

  1. Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Burkina Faso.

PMID: 24106603 PMCID: PMC3787664 DOI: 10.4084/MJHID.2013.053

Abstract

In most sub-Saharan countries screening of blood-transmitted infections includes mainly HIV, HBV, HCV and syphilis. Many viruses such as Hepatitis G (HGV) and Epstein-Barr virus (EBV) which also carry a risk of transmission by blood transfusion raise the question of the extent of screening for these pathogens. This work aims to evaluate the prevalence of HGV and EBV in first-time blood donors in Ouagadougou. The prevalence of HGV and EBV in 551 blood donors was 7.4% and 5.4% respectively. HGV prevalence was significantly higher in blood donors with hepatitis B antigens and positive for HCV compared to donors negative for HCV and no hepatitis B antigens (respectively p<0.001 and p=0.004). EBV prevalence was higher among blood donors of < 20 years age group. HBV and HCV positive individuals are not eligible for blood donation. This study shows significant results with regard to the prevalence of HGV and EBV prevalence in blood donors in Burkina Faso and emphasizes the need for a general screening.

References

  1. Vox Sang. 1998;74(2):83-7 - PubMed
  2. Ter Arkh. 2000;72(11):9-13 - PubMed
  3. Int Urol Nephrol. 2007;39(4):1257-63 - PubMed
  4. East Mediterr Health J. 2005 Sep-Nov;11(5-6):1053-60 - PubMed
  5. J Med Virol. 2000 Feb;60(2):159-65 - PubMed
  6. Am J Trop Med Hyg. 2000 Sep-Oct;63(3-4):192-8 - PubMed
  7. Herpes. 2004 Aug;11(2):50-3 - PubMed
  8. Int J Exp Pathol. 2000 Oct;81(5):305-22 - PubMed
  9. Am J Transplant. 2009 Apr;9(4):794-803 - PubMed
  10. J Anesth. 2013 Dec;27(6):838-43 - PubMed
  11. J Gen Virol. 2011 Feb;92(Pt 2):233-46 - PubMed
  12. Biologicals. 2010 Jan;38(1):39-42 - PubMed
  13. Transfusion. 2000 Jun;40(6):725-30 - PubMed
  14. Virol J. 2011 Feb 28;8:87 - PubMed
  15. J Hepatol. 2011 Apr;54(4):602-3 - PubMed
  16. Nature. 1984 Nov 29-Dec 5;312(5993):449-50 - PubMed
  17. Int J Cancer. 1978 Sep 15;22(3):239-43 - PubMed
  18. Nephrol Dial Transplant. 2002 Feb;17(2):271-5 - PubMed
  19. N Engl J Med. 1996 Jun 6;334(23):1485-90 - PubMed
  20. Cancer Epidemiol Biomarkers Prev. 2001 Jan;10(1):9-16 - PubMed
  21. Transfus Apher Sci. 2013 Dec;49(3):416-21 - PubMed
  22. Nephrol Dial Transplant. 1997 Aug;12(8):1645-51 - PubMed
  23. Br Med Bull. 1998;54(3):731-48 - PubMed
  24. Transfusion. 2000 May;40(5):602-7 - PubMed
  25. Intervirology. 2010;53(6):402-7 - PubMed
  26. Ann Clin Microbiol Antimicrob. 2009 Dec 16;8:36 - PubMed
  27. BMC Infect Dis. 2008 Aug 18;8:111 - PubMed
  28. J Natl Cancer Inst. 1999 Aug 18;91(16):1376-81 - PubMed
  29. J Natl Cancer Inst. 1999 Aug 18;91(16):1349-50 - PubMed
  30. BMC Infect Dis. 2010 May 12;10:115 - PubMed
  31. Acta Chir Iugosl. 2010;57(1):107-13 - PubMed

Publication Types